Johnson & Johnson (JNJ) Raises 2026 Outlook After Q1 Earnings Beat: Is the $100B Revenue Milestone Near?

Johnson & Johnson (JNJ) shares faced minor downward pressure on April 16, 2026, closing at $234.54 despite a robust Q1 earnings report that exceeded analyst expectations. While the stock saw a 1.73% intraday dip, management’s decision to hike full-year 2026 guidance and a 64th consecutive annual dividend increase have solidified the company's blue-chip status among long-term investors.